4
Changes in Ownership
Oncotelic Therapeutics, Inc. Filed Acc 0001493152-21-017102
CHIEF BUSINESS OFFICER acquired 102,519 shares (grant or award)
- CHIEF BUSINESS OFFICER acquired 16,354,961 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Saund Saran · CHIEF BUSINESS OFFICER
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-03-31 | Conversion : show line 1 in the form | +16,354,961 | 16,354,961 | D |
| 2021-07-08 | Grant or award : show line 2 in the form | +102,519 | 16,457,480 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-03-31 | Conversion : show line 3 in the form Series A Convertible Preferred Stock | −16,355 | 0 | D |
| 2021-07-08 | Grant or award : show line 4 in the form Stock Options | +216,279 | 216,279 | D |
Loading xslF345X03/ownership.xml…